Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Animal Health, Inc. (Jaguar Health, Inc.) on June 21, 2016, covering events occurring on June 16, 2016. The company is incorporated in Delaware and maintains its principal executive offices in San Francisco, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
The primary material change reported is the resignation of Philippe Brianceau as Chief Veterinary Officer, effective immediately on June 16, 2016.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the executive departure.
Key Facts for Investor Verification
- Philippe Brianceau resigned as Chief Veterinary Officer effective June 16, 2016.
- The resignation was submitted and accepted immediately.
- No successor was named in this specific filing.
- The report was signed by Karen S. Wright, Chief Financial Officer.